跳至主要内容
临床试验/NCT02225067
NCT02225067已完成2 期

Unblinded Comparison Study for Relationship and Reproducibility Between C13-CAC Breath Test and 24-hour Gastric pH Monitoring, in Patients With Acid-related Diseases and Healthy Volunteers

Otsuka Pharmaceutical Co., Ltd.1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2014年8月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
40
试验地点
1
主要终点
24-hour gastric pH

研究概览

简要总结

The purpose of this study is to compare C13-CAC Breath Test with 24-hour Gastric pH Monitoring in Patients with Gastric Acid-related Diseases and Healthy Volunteers

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
20 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with Gastric Acid-related diseases like peptic ulcer or gastroesophageal reflux disease in investigator's judgment
  • Healthy subjects who are determined no history of Helicobacter pylori infections

排除标准

  • Patients with hypercalcemia
  • Patients with hypothyroidism
  • Patients with hyperparathyroidism
  • History of upper gastrointestinal surgery or resection
  • Any condition would limit the subject's ability to complete 24-hour gastric pH monitoring

研究组 & 干预措施

C13-CAC

Experimental

干预措施: Calcium (13C)Carbonate (Drug)

结局指标

主要结局

24-hour gastric pH

时间窗: from completion of pre-study examination to before C13-CAC adminitration

Gastric pH immediately before taking the C13-CAC and mean gastric pH from a specified time point to the time before C13-CAC administration

13CO2 concentration in expired air

时间窗: 5,10,15,20,25,30,40,50,60,80,100 and 120minutes after C13-CAC administration

13CO2 concentration in expired air, 13CO2 excretion rate in expired air as well as the pharmacokinetic parameters (Cmax, AUCt, AUC∞, tmax, λz, and t1/2) determined from the 13CO2 concentration in expired air and 13CO2 excretion rate in expired air

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验